Picture of Takeda Pharmaceutical Co logo

4502 Takeda Pharmaceutical Co Balance Sheet

0.000.00%
jp flag iconLast trade - 00:00
HealthcareConservativeLarge CapNeutral

Annual balance sheet for Takeda Pharmaceutical Co, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.

C2019
March 31st
2020
March 31st
2021
March 31st
2022
March 31st
2023
March 31st
Period Length:
Source:YuhoYuhoYuhoYuhoYuho
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments725,819653,4361,002,820875,000553,704
Net Total Accounts Receivable
Net Total Receivables749,119784,921812,714724,377681,693
Total Inventory
Total Other Current Assets
Total Current Assets2,993,0372,469,4322,712,8932,593,6422,397,956
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment1,331,9311,386,3701,453,9171,582,8001,691,229
Net Goodwill
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets13,792,77312,821,09412,912,29313,178,01813,957,750
Accounts Payable
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities2,553,0492,175,8981,773,1762,145,7302,481,940
Long Term Debt
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Funded Status
Total Liabilities8,610,7888,097,6117,739,2567,494,9997,603,627
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Unrealized Gain / Loss
Other Equity
Total Equity5,181,9854,723,4835,173,0375,683,0196,354,123
Total Liabilities & Shareholders' Equity13,792,77312,821,09412,912,29313,178,01813,957,750
Total Common Shares Outstanding